ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $27,000 | -87.4% | 52,688 | -77.2% | 0.00% | – |
Q1 2020 | $215,000 | -75.7% | 230,935 | -46.9% | 0.00% | – |
Q4 2019 | $886,000 | -27.5% | 434,521 | +2.2% | 0.00% | -100.0% |
Q3 2019 | $1,222,000 | -47.9% | 425,321 | +39.0% | 0.00% | 0.0% |
Q2 2019 | $2,346,000 | -42.1% | 305,920 | +0.4% | 0.00% | -50.0% |
Q1 2019 | $4,051,000 | -11.1% | 304,786 | +4.2% | 0.00% | 0.0% |
Q4 2018 | $4,558,000 | -18.3% | 292,482 | +3.0% | 0.00% | 0.0% |
Q3 2018 | $5,579,000 | -44.4% | 283,922 | -18.7% | 0.00% | -50.0% |
Q2 2018 | $10,026,000 | +29.7% | 349,302 | +6.8% | 0.00% | +33.3% |
Q1 2018 | $7,732,000 | +20.3% | 326,911 | +9.1% | 0.00% | 0.0% |
Q4 2017 | $6,427,000 | -13.0% | 299,639 | -4.0% | 0.00% | -25.0% |
Q3 2017 | $7,384,000 | +6.7% | 312,239 | -11.1% | 0.00% | +33.3% |
Q2 2017 | $6,920,000 | +15.2% | 351,274 | +22.8% | 0.00% | 0.0% |
Q1 2017 | $6,007,000 | +15.8% | 286,001 | +3.7% | 0.00% | 0.0% |
Q4 2016 | $5,186,000 | -9.1% | 275,880 | +1.0% | 0.00% | 0.0% |
Q3 2016 | $5,704,000 | -40.6% | 273,199 | -27.4% | 0.00% | -50.0% |
Q2 2016 | $9,595,000 | +4.6% | 376,174 | +8.4% | 0.01% | +20.0% |
Q1 2016 | $9,175,000 | +1.6% | 346,921 | +64.3% | 0.01% | 0.0% |
Q4 2015 | $9,032,000 | +25.9% | 211,099 | -22.0% | 0.01% | +25.0% |
Q3 2015 | $7,172,000 | +0.7% | 270,552 | +26.6% | 0.00% | 0.0% |
Q2 2015 | $7,124,000 | +3.3% | 213,710 | +3.1% | 0.00% | 0.0% |
Q1 2015 | $6,896,000 | -13.9% | 207,188 | +5.8% | 0.00% | -20.0% |
Q4 2014 | $8,006,000 | +20.6% | 195,901 | +0.0% | 0.01% | +25.0% |
Q3 2014 | $6,637,000 | -35.2% | 195,885 | -35.6% | 0.00% | -33.3% |
Q2 2014 | $10,250,000 | +56.0% | 304,055 | +75.5% | 0.01% | +50.0% |
Q1 2014 | $6,569,000 | +32.4% | 173,287 | +1.9% | 0.00% | +33.3% |
Q4 2013 | $4,963,000 | -19.1% | 169,988 | -5.0% | 0.00% | -25.0% |
Q3 2013 | $6,135,000 | +7.1% | 178,955 | +3.1% | 0.00% | 0.0% |
Q2 2013 | $5,727,000 | – | 173,602 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |